Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 16CNS 3Gastrointestinal 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Lung Neoplasms 1332Carcinoma, Non-Small-Cell Lung 631Breast Neoplasms 162Neoplasms 99Small Cell Lung Carcinoma 93Prostatic Neoplasms 86Colorectal Neoplasms 79Motor Activity 63Colonic Neoplasms 62Head and Neck Neoplasms 60Esophageal Neoplasms 49Disease 46Pancreatic Neoplasms 45Melanoma 41Stomach Neoplasms 39Urinary Bladder Neoplasms 37Ovarian Neoplasms 37Pleural Effusion, Malignant 36Neoplasm Metastasis 35Brain Neoplasms 29Gastrointestinal Neoplasms 28Pulmonary Disease, Chronic Obstructive 27Anxiety Disorders 27Lung Diseases 26Liver Neoplasms 26Carcinoma, Renal Cell 26Adenocarcinoma of Lung 26Thoracic Neoplasms 25Mesothelioma 24Lymphoma 24

Interventions

Nadroparin 1Fondaparinux 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Venous Thromboembolism × Thoracic × Clear all
NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Shanghai Zhongshan Hospital

Phase NA Completed
362 enrolled
Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡